Skip Navigation
Department of Health and Human Services
Slide Tray
0 slides

Return to Slide Library


Add Presentation to Slide Tray Presentation:

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Slide: 15 of 37

Characteristics of Trials of rhGH Treatment for Patients With CF

The trials of rhGH treatment for patients with CF shared these characteristics:

  1. Nutritional needs were addressed for all patients before enrollment.
  2. Both pubertal and prepubertal patients were enrolled.
  3. Trials were conducted over 6 to 12 months.
  4. The most commonly used dosage schedule was 0.3 mg/kg/week divided into equal daily doses. Doses ranged from 0.27 to 0.49 mg/kg/week.